Bailey L C, Levine N A
Department of Pharmaceutical Chemistry, Rutgers University, College of Pharmacy, Piscataway, NJ 08855-0789.
J Pharm Biomed Anal. 1993 Apr-May;11(4-5):285-92. doi: 10.1016/0731-7085(93)80019-w.
The current USP XXII assay for hyaluronidase (EC 3.2.1.35, HAse) determines activity indirectly by measuring the amount of undegraded hyaluronic acid (HA) substrate remaining after the enzyme is allowed to react with the HA for 30 min at 37 degrees C. To be acceptable as a substrate, the HA must pass a USP suitability test. In this study, seven HA samples, which differed in their anatomical origin, their commercial supplier, and their chondroitin sulphate content, were tested as substrates. One of these did not pass the USP suitability test and therefore would not be an officially acceptable substrate; however, it was carried through the investigation along with the others in order to demonstrate its effect on the analysis. All seven HAs were used as substrates to assay testicular hyaluronidases from three different suppliers. The standard by which the other hyaluronidase activities were measured was USP hyaluronidase reference standard. The activity values calculated for a particular hyaluronidase differed significantly depending on which HA was used as substrate in its assay. Optimal results, as judged on the bases of initial purity, suitability for the assay, linearity of the standard curve, and per cent relative standard deviation of the measured activity, were obtained with a HA substrate derived from vitreous humour.
美国药典第XXII版目前的透明质酸酶(EC 3.2.1.35,HAse)测定法,是通过测量在37摄氏度下酶与透明质酸(HA)反应30分钟后剩余的未降解HA底物的量来间接测定活性。作为底物,HA必须通过美国药典适用性测试。在本研究中,测试了七个HA样品,它们在解剖来源、商业供应商和硫酸软骨素含量方面存在差异。其中一个未通过美国药典适用性测试,因此不是官方认可的底物;然而,为了证明其对分析的影响,它与其他样品一起进行了研究。所有七个HA都用作底物,以测定来自三个不同供应商的睾丸透明质酸酶。用于测量其他透明质酸酶活性的标准是美国药典透明质酸酶参考标准品。根据用作测定底物的HA不同,计算出的特定透明质酸酶的活性值有显著差异。以初始纯度、对测定的适用性、标准曲线的线性以及测量活性的相对标准偏差百分比为依据判断,使用源自玻璃体液的HA底物可获得最佳结果。